CGM for insulin-treated type 2 diabetes after hospital discharge
Part of Hormones & metabolism clinical trials.
This study tests whether using a continuous glucose monitor (CGM) can help people with type 2 diabetes who need insulin after leaving the hospital. It aims to improve blood sugar control during this transition period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have type 2 diabetes.
- Your average blood sugar (HbA1c) is between 8.0% and 13.0% in the last month.
- Your doctor plans for you to use insulin for at least 6 months after leaving the hospital.
- You have not used a real-time CGM in the past 3 months.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a continuous glucose monitor (CGM) after leaving the hospital helps manage diabetes. You wear a small sensor on your arm that checks your sugar levels all day and sends them to your phone.
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
This study tests whether using a continuous glucose monitor (CGM) after leaving the hospital helps people with diabetes avoid being readmitted. If you have high blood sugar and need insulin at home, this device might help you manage better.
This trial tests whether using a continuous glucose monitor (CGM) after leaving the hospital helps people with type 2 or steroid-related diabetes manage their blood sugar with insulin. It is for adults who were treated in the hospital and need insulin when they go home.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.